---
figid: PMC2862093__nihms191985f6
figlink: /pmc/articles/PMC2862093/figure/F6/
number: F6
caption: In our previous work we demonstrated that GLP-1 or Exendin-4 increased cAMP
  production. Here we propose that the GLP-1 action shares key downstream components
  of the insulin signaling pathway, including PKCζ, which has been shown to be a key
  factor in NAFLD.
pmcid: PMC2862093
papertitle: Glucagon-like Peptide-1 Receptor (GLP-1R) is present on human hepatocytes
  and has a direct role in decreasing hepatic steatosis in vitro by modulating elements
  of the insulin signaling pathway.
reftext: Nitika Arora Gupta, et al. Hepatology. ;51(5):1584-1592.
pmc_ranked_result_index: '36696'
pathway_score: 0.9221876
filename: nihms191985f6.jpg
figtitle: Glucagon-like Peptide-1 Receptor (GLP-1R) is present on human hepatocytes
  and has a direct role in decreasing hepatic steatosis in vitro by modulating elements
  of the insulin signaling pathway
year: ''
organisms:
- Homo sapiens
ndex: e41f80a8-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2862093__nihms191985f6.html
  '@type': Dataset
  description: In our previous work we demonstrated that GLP-1 or Exendin-4 increased
    cAMP production. Here we propose that the GLP-1 action shares key downstream components
    of the insulin signaling pathway, including PKCζ, which has been shown to be a
    key factor in NAFLD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCH
  - NMUR1
  - AKT1
  - AKT3
  - PRKD3
  - IRS4
  - GLP1R
  - PRKCG
  - PRKCD
  - AKT2
  - SLC2A2
  - PRKCE
  - PDK2
  - PI3
  - PRKCI
  - PRKCQ
  - PRKCB
  - PDK1
  - IRS2
  - PRKCA
  - PRKCZ
  - Cancer
genes:
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: IRS-3/4
  symbol: IRS-4
  source: hgnc_alias_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: GLP1-R
  symbol: GLP1R
  source: hgnc_symbol
  hgnc_symbol: GLP1R
  entrez: '2740'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: GLUT2
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PDK2
  symbol: PDK2
  source: hgnc_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PI3
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: IRS-1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC/
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2862093__F6
redirect_from: /figures/PMC2862093__F6
figtype: Figure
---
